All Type of News
HIRAS to evaluate economic effectiveness of antihypertensive agents
The Health Insurance Review Assessment and Services (HIRAS) said it plans to start re-evaluating the cost effectiveness of insurance-covered antihypertensive drugs under its consultation with the Health Ministry.
T...
Wholesalers, drugmakers on same path on new drug pricing reform
Domestic wholesalers and pharmaceutical manufacturers are in agreement that a "comprehensive and definitive" approach is required to comply with the government’s aggressive plan to pay medical institutions and drug st...
Bill to crack down on bribe-taking doctors
When it comes to bribery in the medical field, it is usual that the companies offering the bribes are subject to prosecution in the local pharmaceutical industry.
In the future, however, those who accept kickbacks...
6-year pharmacy college selection to be made public on Feb. 26
The Ministry of Education, Science and Technology announced on February 18 the first list of 19 successful candidates for six-year pharmacy schools, all of which are in the provinces. 32 universities have already appl...
KFDA warns misuse or overuse of drugs
Not many people read the dosage instructions on the back or inside medicine packages but they should, as thee of 10 adults have taken illegally distributed impotence drugs last year.
According to a survey of the Ko...
Special committee to head KPMA until Feb. 25
A 7-member special committee will be set up to deal with the key affairs of the Korea Pharmaceutical Manufacturers Association as the group's president Auh June-sun recently offered to resign in protest against the go...
Successful strategies proposed over biosimilars
Drug manufacturers need to recognize that three factors – better formulation method, timing and cost competitiveness – should be essential to make their biosimilars successful in the global market, according to a loca...
Concerns mounting over for-profit foreign hospital inIFEZ
The government is seeking the revision of the Medical Law to allow Koreans full access to foreign medical facilities inside the Incheon Free Economic Zone (IFEZ) for the first five years after they open, in order to b...
Korea’s trade deficit for medicine narrows in 2009
The country’s trade imbalance in drugs topped $2.20 billion last year, compared with $2.68 billion in 2008, according to the report by the Korea Pharmaceutical Traders Association.
By finished products, exports sto...
Handok, Novartis Korea strengthen strategic alliance
Handok Pharm said it will co-market new oral treatment released by Novartis, called Galvusmet, a combination of vildagliptin and metformin, here in Korea.
To this end, Handok and Novartis Korea signed an agreement ...
